Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Highlands Stable Isotopes Corporation (HSI) is a non-profit research and commercialization entity operating as a component unit of New Mexico Highlands University. Established in 2009, the company focuses on the development and synthesis of novel isotopically labeled precursors, including amino acids, heterocyclic compounds, and natural products, for use in life sciences and materials research. HSI is recognized for its patented technologies that facilitate the creation of specialized stable isotope synthons used in high-resolution NMR, metabolomics, and pharmaceutical development. The company maintains a global reach through a strategic distribution agreement with Sigma-Aldrich (MilliporeSigma), providing high-purity labeled reagents to the international scientific community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Highlands Stable Isotopes.